Step 1 topics → Reproductive → PDE5 Inhibitors (Sildenafil, Tadalafil)

PDE5 Inhibitors (Sildenafil, Tadalafil)

USMLE Step 1 trap: Understates the mechanism of PDE5 inhibitor–nitrate interaction as additive rather than synergistic cGMP accumulation. PDE5 inhibitors potentiate nitrate-induced hypotension by preventing cGMP degradation while nitrates increase cGMP production, causing synergistic and potentially fatal vasodilation.

PDE5 inhibitors — sildenafil (Viagra), tadalafil (Cialis), vardenafil — are the first-line pharmacological treatment for erectile dysfunction, and USMLE Step 1 tests them from two main angles: the signaling mechanism and the clinical consequences (side effects, contraindications, drug interactions). The mechanism question requires you to trace the full NO → cGMP → smooth muscle relaxation pathway and understand exactly where PDE5 inhibition fits in — not as a generator of cGMP but as a brake on its degradation. The clinical questions tend to show a vignette where someone with angina or pulmonary hypertension is on a nitrate or nitric oxide donor, and you need to recognize why combining it with sildenafil is dangerous.

What makes this topic trip students up is a persistent confusion between 'increasing cGMP' and 'preventing cGMP breakdown.' They're not the same thing, and the distinction matters for both the mechanism question and the nitrate interaction question. Sildenafil does nothing on its own without prior sexual stimulation — there has to be NO-mediated cGMP synthesis first, and then PDE5 inhibition prolongs that signal. If you miss that, you'll misclassify how the drug works and why it's contraindicated with nitrates.

The other commonly missed fact is the visual side effect: sildenafil has enough cross-reactivity with PDE6 (found in retinal photoreceptors) to cause transient blue-green color disturbances (cyanopsia). USMLE Step 1 occasionally includes this as a 'which side effect is associated with this drug' question, and students who only memorized headache and flushing get caught off guard. Tadalafil, by contrast, is more selective and is also approved for BPH and pulmonary arterial hypertension — details that sometimes appear in application-style vignettes.

From real student decks
73%have cards covering this topic
54%have mature cards

Common misconceptions

Common mistake
Wrong: PDE5 inhibitors are contraindicated with nitrates only because both lower blood pressure.
Right: PDE5 inhibitors potentiate nitrate-induced hypotension by preventing cGMP degradation while nitrates increase cGMP production, causing synergistic and potentially fatal vasodilation.
Calling this interaction 'additive hypotension' undersells the mechanism and will lead you to misjudge its severity. Nitrates work by releasing NO, which activates guanylyl cyclase to produce cGMP. PDE5 inhibitors block the enzyme that breaks cGMP down. Hit both pathways simultaneously and cGMP accumulates far beyond what either drug alone produces — that's a synergistic, not simply additive, effect. The resulting vasodilation can cause catastrophic hypotension, which is why this combination is an absolute contraindication, not just a 'use caution' warning.
Common mistake
Wrong: Sildenafil directly increases cGMP production in penile smooth muscle.
Right: Sildenafil inhibits PDE5, which normally degrades cGMP; it requires prior NO-mediated cGMP synthesis (from sexual stimulation) and does not generate cGMP itself.
Sildenafil is not a cGMP producer — it's a cGMP preserver. The drug only works when there's already cGMP being synthesized, which requires NO release from endothelial cells and neurons during sexual stimulation. PDE5 normally degrades that cGMP; sildenafil blocks PDE5 and extends cGMP's duration of action. This is why PDE5 inhibitors don't cause erections without stimulation and why they fail if NO signaling is impaired (e.g., in men with severe vascular disease or after radical prostatectomy damaging cavernous nerves).
Common mistake
Gap: Missing that sildenafil's PDE6 cross-reactivity causes transient visual color disturbance
Sildenafil can inhibit PDE6 in retinal photoreceptors, causing transient blue-green color vision disturbance (cyanopsia) as a side effect.
PDE5 is structurally similar to PDE6, which is expressed in retinal rod and cone photoreceptors and plays a critical role in phototransduction. At higher doses, sildenafil crosses over and partially inhibits PDE6, altering the visual signal and producing a transient blue-green tint to vision (cyanopsia) or difficulty distinguishing blue from green. This is a classic sildenafil-specific factoid on USMLE Step 1 — tadalafil is more PDE5-selective and causes this much less commonly, making it a useful distinguishing feature between agents in the class.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Trace the mechanism: how PDE5 inhibition preserves cGMP (made by guanylyl cyclase via NO) and leads to smooth muscle relaxation in penile vasculature — understanding PDE5 as a degrader of cGMP, not a source of it.
  2. Identify why PDE5 inhibitors are absolutely contraindicated with nitrates (nitroglycerin, isosorbide, amyl nitrite) — nitrates increase cGMP production while PDE5 inhibitors block its breakdown, causing synergistic, potentially fatal hypotension.
  3. Recognize sildenafil-specific side effects including headache, flushing, and — importantly — transient blue-green color vision disturbance (cyanopsia) due to off-target PDE6 inhibition in retinal photoreceptors.
  4. Apply knowledge of tadalafil's longer half-life and additional indications (pulmonary arterial hypertension, BPH) and recognize that the same nitrate contraindication applies to all drugs in this class.

Can you avoid these mistakes?

A 58-year-old man with stable angina takes sublingual nitroglycerin as needed. He asks his doctor about sildenafil for erectile dysfunction. Why is this combination absolutely contraindicated, and what is the specific molecular mechanism underlying the danger?
A patient takes sildenafil and reports that colors look 'bluish' for a few hours after each dose. Which enzyme is responsible for this side effect, where is it expressed, and what is its normal physiological role?
A man with erectile dysfunction tries sildenafil but reports no effect. His workup shows he has significant atherosclerosis of penile vasculature and likely impaired endothelial NO synthase activity. Based on the drug's mechanism, why would this patient be a poor responder?
Tadalafil is approved for three different conditions. Name all three and explain which pharmacokinetic property distinguishes it from sildenafil in clinical practice.

Related topics

Erectile Dysfunction Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →